V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004855 | 220001912 | 1.77 | 68 | Adjuvant (A) | 2017-08-25 | 2017-08-29 | AML17 TRIAL | 02 | N | 220026936 | AML17 TRIAL |
| 220004856 | 220001912 | null | 64.2 | Curative (C) | 2016-07-15 | 2016-07-15 | AML17 TRIAL | 01 | null | 220026936 | AML17 TRIAL |
| 220004857 | 220001912 | 1.45 | null | Palliative (P) | null | 2016-04-01 | Cytarabine low (10to20mg/m2) IV/SC | 2 | Y | 220026936 | CYTARABINE |
| 220004858 | 220001912 | 1.65 | 54.1 | Disease modification (D) | 2014-08-09 | 2014-09-25 | LI-1 TRIAL | Y | N | 220026936 | TRIAL |
| 220004862 | 220001914 | 1.49 | 76 | Curative (C) | 2017-06-21 | 2017-06-21 | AML17 TRIAL | Y | N | 220026952 | AML17 TRIAL |
| 220004863 | 220001914 | null | 77.4 | Curative (C) | 2016-06-11 | 2016-06-20 | AML17 TRIAL | 2 | null | 220026952 | AML17 TRIAL |
| 220004864 | 220015868 | null | 86.5 | Palliative (P) | 2013-05-08 | 2013-05-08 | LI-1 TRIAL | 01 | N | 220026958 | TRIAL |
| 220004865 | 220001915 | null | 92 | Curative (C) | 2016-07-07 | 2016-07-07 | Trial Unspecified | Y | N | 220026960 | TRIAL |
| 220004866 | 220010992 | 1.55 | null | Curative (C) | 2016-11-10 | 2016-11-12 | Trial Unspecified | Y | null | 220026961 | TRIAL |
| 220004867 | 220010992 | 1.8 | 77 | Palliative (P) | 2015-09-29 | 2015-10-04 | Trial Unspecified | Y | null | 220026961 | TRIAL |
| 220004868 | 220010992 | 1.75 | 83.9 | Curative (C) | 2013-03-18 | 2013-03-19 | AML17 TRIAL | Y | N | 220026961 | AML17 TRIAL |
| 220004871 | 220001917 | 1.62 | 38 | Curative (C) | 2015-08-12 | 2015-08-12 | AML17 TRIAL | N | N | 220026968 | AML17 TRIAL |
| 220004873 | 220001919 | 1.63 | null | Palliative (P) | 2016-09-19 | 2016-09-19 | Trial Unspecified | Y | N | 220026971 | TRIAL |
| 220004874 | 220001919 | 1.65 | null | Not known (9) | 2016-11-18 | 2016-11-18 | AML17 TRIAL | 02 | N | 220026971 | AML17 TRIAL |
| 220004875 | 220001919 | 1.71 | 116 | Curative (C) | 2015-11-16 | 2015-11-16 | AML17 TRIAL | null | N | 220026971 | AML17 TRIAL |
| 220004876 | 220001919 | 1.65 | null | null | null | 2013-05-10 | CYTARABINE | null | null | 220026971 | CYTARABINE |
| 220004877 | 220001919 | 1.63 | 60.9 | null | 2015-06-18 | 2015-06-22 | AML17 TRIAL | 2 | N | 220026971 | AML17 TRIAL |
| 220004878 | 220001919 | 1.76 | null | Palliative (P) | 2014-01-11 | 2014-01-23 | CYTARABINE | null | N | 220026971 | CYTARABINE |
| 220004879 | 220001919 | 1.57 | null | Curative (C) | 2015-03-30 | 2015-03-30 | AML17 TRIAL | N | null | 220026971 | AML17 TRIAL |
| 220004880 | 220001919 | null | null | Palliative (P) | 2016-02-04 | 2016-02-04 | Cytarabine Low Dose | N | N | 220026971 | CYTARABINE |
| 220004881 | 220001920 | null | 76 | Not known (9) | null | 2015-03-14 | AML17 TRIAL | null | null | 220026990 | AML17 TRIAL |
| 220004882 | 220001920 | 1.52 | 73 | Curative (C) | 2014-05-17 | 2014-05-17 | Trial Unspecified | 1 | N | 220026990 | TRIAL |
| 220004883 | 220001920 | 0 | 81.4 | Not known (9) | 2013-10-12 | 2013-10-19 | AML17 TRIAL | Y | N | 220026990 | AML17 TRIAL |
| 220004884 | 220001921 | 1.64 | null | Palliative (P) | 2016-04-11 | 2016-04-14 | CYTARABINE | null | N | 220026998 | CYTARABINE |
| 220004885 | 220001921 | 1.77 | 68.8 | Radical (R) | 2015-04-27 | 2015-04-30 | AML17 TRIAL | 1 | N | 220026998 | AML17 TRIAL |
| 220004886 | 220001922 | null | 50.6 | Palliative (P) | 2013-05-05 | 2013-05-06 | Cytarabine Low Dose | 01 | N | 220027001 | CYTARABINE |
| 220004887 | 220001922 | null | null | Curative (C) | 2016-08-27 | 2016-08-27 | AML17 TRIAL | 01 | N | 220027001 | AML17 TRIAL |
| 220004888 | 220001922 | 1.7 | null | Curative (C) | 2014-11-23 | 2014-11-23 | AML17 TRIAL | 1 | null | 220027001 | AML17 TRIAL |
| 220004889 | 220001923 | 1.68 | 73 | null | 2016-12-03 | 2016-12-03 | AML17 TRIAL | 01 | null | 220027011 | AML17 TRIAL |
| 220004890 | 220001924 | 0 | null | null | 2013-08-25 | 2013-09-08 | Cytarabine Low Dose | null | N | 220027013 | CYTARABINE |
| 220004891 | 220001924 | 0 | 65 | Not known (9) | 2013-12-01 | 2013-12-03 | Cytarabine Low Dose | 02 | N | 220027013 | CYTARABINE |
| 220004892 | 220001924 | 1.67 | null | null | 2017-03-20 | 2017-03-28 | Cytarabine Low Dose | 2 | N | 220027013 | CYTARABINE |
| 220004893 | 220001925 | 1.56 | 71.4 | Palliative (P) | 2015-12-09 | 2015-12-09 | Trial Unspecified | 01 | N | 220027021 | TRIAL |
| 220004894 | 220001925 | 1.7 | null | Palliative (P) | 2016-04-04 | 2016-04-07 | Cytarabine Low Dose | null | null | 220027021 | CYTARABINE |
| 220004895 | 220001926 | null | 88.3 | null | 2017-06-19 | 2017-06-19 | AML17 TRIAL | Y | N | 220027025 | AML17 TRIAL |
| 220004896 | 220001926 | 1.62 | 83.5 | Disease modification (D) | 2015-06-29 | 2015-07-02 | Trial Unspecified | 01 | N | 220027025 | TRIAL |
| 220004897 | 220001926 | null | 51.5 | Palliative (P) | null | 2014-05-08 | CYTARABINE | null | null | 220027025 | CYTARABINE |
| 220004898 | 220001926 | null | 73.4 | Palliative (P) | 2015-12-24 | 2015-12-24 | CYTARABINE | 02 | null | 220027025 | CYTARABINE |
| 220004899 | 220001926 | 1.79 | null | Curative (C) | 2013-02-24 | 2013-02-24 | AML17 TRIAL | N | N | 220027025 | AML17 TRIAL |
| 220004900 | 220001927 | 1.88 | 68.4 | Palliative (P) | 2015-03-30 | 2015-04-04 | CYTARABINE | 02 | N | 220027032 | CYTARABINE |
| 220004901 | 220001928 | 1.75 | 91 | Curative (C) | 2016-05-30 | 2016-05-31 | AML17 TRIAL | 01 | N | 220027033 | AML17 TRIAL |
| 220004902 | 220001929 | null | null | Palliative (P) | null | 2014-02-04 | CYTARABINE | N | N | 220027034 | CYTARABINE |
| 220004903 | 220001930 | null | 72.5 | Not known (9) | 2015-10-20 | 2015-10-20 | Trial Unspecified | Y | N | 220027038 | TRIAL |
| 220004904 | 220001930 | 1.67 | null | null | null | 2013-03-16 | CYTARABINE | null | null | 220027038 | CYTARABINE |
| 220004905 | 220001930 | 1.85 | null | Curative (C) | 2015-01-05 | 2015-01-06 | AML17 TRIAL | 02 | N | 220027038 | AML17 TRIAL |
| 220004906 | 220001930 | 0 | 77.8 | Disease modification (D) | 2014-09-15 | 2014-09-15 | CYTARABINE | 02 | null | 220027038 | CYTARABINE |
| 220004907 | 220001930 | 1.7 | 88.3 | null | 2015-10-31 | 2015-10-31 | Cytarabine Low Dose | null | N | 220027038 | CYTARABINE |
| 220004908 | 220001931 | 1.79 | 0 | Not known (9) | 2013-12-02 | 2013-12-04 | Cytarabine Low Dose | 2 | N | 220027049 | CYTARABINE |
| 220004909 | 220001931 | 1.65 | 140 | Palliative (P) | 2013-04-28 | 2013-04-28 | Trial Unspecified | Y | N | 220027049 | TRIAL |
| 220004910 | 220001931 | 1.64 | null | Not known (9) | 2015-01-04 | 2015-01-06 | AML17 TRIAL | 1 | null | 220027049 | AML17 TRIAL |